How well beta-lactam antibiotics reach tissue in critically ill children
Official title: TACTIC Study: Tissue Penetration of Antibiotics in CriTically Ill Children
Run by University Hospital, Ghent · NCT07822243 · Data updated 2026-11-12
This study tests whether three common beta-lactam antibiotics reach sufficient tissue levels in the muscles of critically ill children.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Month to 15 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | October 1, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07822243 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are critically ill children aged 1 month to 15 years in the PICU who require one of the three study antibiotics and have appropriate vascular access.
✕Probably not a fit
Patients whose clinical course does not involve the studied antibiotics or who cannot undergo microdialysis may not benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational pharmacokinetic study in a single center. It uses microdialysis to measure unbound antibiotic concentrations in interstitial tissue fluid during initial dosing and at steady state in pediatric patients with critical illness who are receiving piperacillin-tazobactam, meropenem, or amoxicillin-clavulanic acid. The study also looks at how patient characteristics affect antibiotic disposition in muscle tissue. Microdialysis catheters are placed in muscle with continuous analgesia for sampling, alongside blood measurements to compare tissue and plasma levels. The goal is to see if tissue drug levels meet predefined pharmacokinetic/pharmacodynamic targets to inform dosing in this vulnerable population.
Why it matters
Potential benefit: If successful, the findings could help tailor antibiotic dosing to achieve effective tissue concentrations in critically ill children, potentially improving treatment outcomes.
How similar studies have gone: Prior adult studies suggest tissue levels can differ from plasma levels, but pediatric tissue PK data are limited and this study is among the first in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient admitted to the Pediatric Intensive Care Unit (PICU). * Age: 1 month to 15 years. * Receiving intravenous antibiotic treatment with piperacillin-tazobactam, meropenem, or amoxicillin-clavulanic acid. * Receiving continuous analgosedation (required for microdialysis catheter insertion; if analgosedation is stopped after insertion, the catheter may remain in place). * Intra-arterial (preferred) or intravenous access available for blood sampling. Exclusion Criteria: * Presence of coagulopathy and/or thrombocytopenia: * Platelet count \< 50,000/µL * International Normalized Ratio (INR) \> 1.5 * Activated partial thromboplastin time (aPTT) \> 1.5 x upper limit of normal value (age-specific thresholds: \> 50 sec for 30-90 days; \> 42 sec for 90-180 days; \> 38 sec for \> 180 days) * Personal or family history of excessive bleeding. * Current treatment with coumarin derivative anticoagulants. * Known hypersensitivity to beta-lactam antibiotics. * Pregnancy. * Absence of parental (or legal guardian) informed consent. * Absence of suitable catheter for blood sampling.
Where it's running
-
Ghent University Hospital
Ghent, Belgium Recruiting
Study contacts
- Principal investigator: Pieter De Cock, Prof. — University Hospital, Ghent
- Study coordinator: Pieter De Cock, Prof.
- Email: pieter.decock@uzgent.be
- Phone: +32 9 332 29 69
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.